XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.1
Note 9 - Segment Information and Disaggregated Revenue (Tables)
9 Months Ended
Mar. 31, 2025
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   Sales, Net  Segment        
   

U.S.

  

International

      

Gross

      

Capital

 
   

Customers

  

Customers

  

Total

  

Profit (loss)

  

Depreciation

  

Expenditures

 

Contract Manufacturing

2025

 $10,231  $3,228  $13,459  $1,522  $76  $116 
 

2024

  10,770   1,980   12,750   1,250   77   345 
                          

Other Nutraceutical Businesses

2025

  488   -   488   29   -   - 
 

2024

  397   -   397   (2)  -   - 
                          

Total Company

2025

  10,719   3,228   13,947   1,551   76   116 
 

2024

  11,167   1,980   13,147   1,248   77   345 
   

Sales, Net

  

Segment

         
   

U.S.

  

International

      

Gross

      

Capital

 
   

Customers

  

Customers

  

Total

  

Profit

  

Depreciation

  

Expenditures

 

Contract Manufacturing

2025

 $30,334  $7,768  $38,102  $3,497  $246  $201 
 

2024

  31,022   5,218   36,240   2,563   231   404 
                          

Other Nutraceutical Businesses

2025

  2,076   -   2,076   596   1   - 
 

2024

  1,304   27   1,331   37   1   3 
                          

Total Company

2025

  32,410   7,768   40,178   4,093   247   201 
 

2024

  32,326   5,245   37,571   2,600   232   407 
  

Total Assets as of

 
  

March 31,

  

June 30,

 
  

2025

  

2024

 
         

Contract Manufacturing

 $19,880  $20,830 
Other Nutraceutical Businesses  5,776   5,377 

Total Company

 $25,656  $26,207